Genes in which we observed enriched variants include APOE, LIPC and APOA5, whose role in dyslipidemias is already established, but also include several genes whose function in lipid metabolism is not yet clear (e. g. UBR1, MTHFD2L and the PIGV-NR0B2 region). The gene discussed is NR0B2; the disease is metabolic syndrome.